Loading…
Histologically confirmed distant metastatic urothelial carcinoma from the urinary bladder: a retrospective review of one institution's 20-year experience
Urothelial carcinoma (UC) accounts for roughly 90% of bladder cancer, and has a high propensity for diverse differentiation. Recently, certain histologic variants of UC have been recognized to be associated with unfavorable clinical outcomes. Several UC studies have also suggested that tumor budding...
Saved in:
Published in: | Journal of pathology and translational medicine 2021, 55(2), , pp.94-101 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c4369-22ab409c4cb13c08c13da42115f1d5d2a17d4713aa7e401e1778f9d20dac14d3 |
---|---|
cites | cdi_FETCH-LOGICAL-c4369-22ab409c4cb13c08c13da42115f1d5d2a17d4713aa7e401e1778f9d20dac14d3 |
container_end_page | 101 |
container_issue | 2 |
container_start_page | 94 |
container_title | Journal of pathology and translational medicine |
container_volume | 55 |
creator | Yoo, Youngeun Lee, Junghye Park, Heae Surng Cho, Min-Sun Sung, Sun Hee Park, Sanghui Choi, Euno |
description | Urothelial carcinoma (UC) accounts for roughly 90% of bladder cancer, and has a high propensity for diverse differentiation. Recently, certain histologic variants of UC have been recognized to be associated with unfavorable clinical outcomes. Several UC studies have also suggested that tumor budding is a poor prognostic marker. Distant metastasis of UC after radical cystectomy is not uncommon. However, these metastatic lesions are not routinely confirmed with histology.
We investigated the histopathologic features of 13 cases of UC with biopsy-proven distant metastases, with a special emphasis on histologic variants and tumor budding.
Lymph nodes (6/13, 46%) were the most common metastatic sites, followed by the lung (4/13, 31%), liver (4/13, 31%), and the adrenal gland (2/13, 15%). The histologic variants including squamous (n=1), micropapillary (n=4), and plasmacytoid (n=1) variants in five cases of UC. Most histologic variants (4/5, 80%) of primary UCs appeared in the metastatic lesions. In contrast, high-grade tumor budding was detected in six cases (46%), including one case of non-muscle invasive UC. Our study demonstrates that histologic variants are not uncommonly detected in distant metastatic UCs. Most histologic variants seen in primary UCs persist in the distant metastatic lesions. In addition, high-grade tumor budding, which occurs frequently in primary tumors, may contribute to the development of distant metastasis.
Therefore, assessing the presence or absence of histologic variants and tumor budding in UCs of the urinary bladder, even in non-muscle invasive UCs, may be useful to predict distant metastasis. |
doi_str_mv | 10.4132/jptm.2020.10.19 |
format | article |
fullrecord | <record><control><sourceid>proquest_nrf_k</sourceid><recordid>TN_cdi_nrf_kci_oai_kci_go_kr_ARTI_9763112</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_35298fcc0ad64d1da774551d0e093f75</doaj_id><sourcerecordid>2504869268</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4369-22ab409c4cb13c08c13da42115f1d5d2a17d4713aa7e401e1778f9d20dac14d3</originalsourceid><addsrcrecordid>eNpdUk1vEzEQXSEQrUrP3JAlDsAhqb92veaAVFVAI1VCQrlbE3s2dbprB68TyE_h3-IkJaKcZvzm-Wk-XlW9ZnQqmeBXq3UeppxyOi0I08-qcy5aMVGtrJ-fcqHOqstxXFFKmaxFI_XL6kwI3lDe1ufV71s_5tjHpbfQ9ztiY-h8GtARVwoQMhkwQ8myt2STYr7H3kNPLCTrQxyAdCkOpMCl6gOkHVn04BymjwRIwpziuEab_RbLa-vxJ4kdiQGJD2P2eZN9DO9Gwulkh5AI_lpj8hgsvqpedNCPePkYL6r5l8_zm9vJ3bevs5vru4mVotETzmEhqbbSLpiwtLVMOJCcsbpjrnYcmHJSMQGgUFKGTKm2045TB5ZJJy6qD0fZkDrzYL2J4A9xGc1DMtff5zOjVSMY44U7O3JdhJVZJz-UeQ8fDkBMSwOpLKpHI2qu285aCq6RjjlQStY1cxSpFp2qi9ano9Z6syjrthhygv6J6NNK8Pelp61RulU1Z0Xg_aNAij82OGYz-NFi30PAuBkNl03DNVdaF-rb_6iruEmhbNXwmsq20bxpC-vqyLLlZmPC7tQMo2ZvOLM3nNkbbo-wve6bf2c48f_aS_wBToPUmw</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2504869268</pqid></control><display><type>article</type><title>Histologically confirmed distant metastatic urothelial carcinoma from the urinary bladder: a retrospective review of one institution's 20-year experience</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Yoo, Youngeun ; Lee, Junghye ; Park, Heae Surng ; Cho, Min-Sun ; Sung, Sun Hee ; Park, Sanghui ; Choi, Euno</creator><creatorcontrib>Yoo, Youngeun ; Lee, Junghye ; Park, Heae Surng ; Cho, Min-Sun ; Sung, Sun Hee ; Park, Sanghui ; Choi, Euno</creatorcontrib><description>Urothelial carcinoma (UC) accounts for roughly 90% of bladder cancer, and has a high propensity for diverse differentiation. Recently, certain histologic variants of UC have been recognized to be associated with unfavorable clinical outcomes. Several UC studies have also suggested that tumor budding is a poor prognostic marker. Distant metastasis of UC after radical cystectomy is not uncommon. However, these metastatic lesions are not routinely confirmed with histology.
We investigated the histopathologic features of 13 cases of UC with biopsy-proven distant metastases, with a special emphasis on histologic variants and tumor budding.
Lymph nodes (6/13, 46%) were the most common metastatic sites, followed by the lung (4/13, 31%), liver (4/13, 31%), and the adrenal gland (2/13, 15%). The histologic variants including squamous (n=1), micropapillary (n=4), and plasmacytoid (n=1) variants in five cases of UC. Most histologic variants (4/5, 80%) of primary UCs appeared in the metastatic lesions. In contrast, high-grade tumor budding was detected in six cases (46%), including one case of non-muscle invasive UC. Our study demonstrates that histologic variants are not uncommonly detected in distant metastatic UCs. Most histologic variants seen in primary UCs persist in the distant metastatic lesions. In addition, high-grade tumor budding, which occurs frequently in primary tumors, may contribute to the development of distant metastasis.
Therefore, assessing the presence or absence of histologic variants and tumor budding in UCs of the urinary bladder, even in non-muscle invasive UCs, may be useful to predict distant metastasis.</description><identifier>ISSN: 2383-7837</identifier><identifier>EISSN: 2383-7845</identifier><identifier>DOI: 10.4132/jptm.2020.10.19</identifier><identifier>PMID: 33260285</identifier><language>eng</language><publisher>Korea (South): Korean Society of Pathologists, Korean Society for Cytopathology</publisher><subject>Adrenal glands ; Biopsy ; Bladder cancer ; bladder neoplasms ; Clinical outcomes ; distant metastasis ; histologic variant ; Liver ; Lymphatic system ; Metastasis ; Original ; Patients ; tumor budding ; Tumors ; urothelial carcinoma ; 병리학</subject><ispartof>Journal of Pathology and Translational Medicine, 2021, 55(2), , pp.94-101</ispartof><rights>2021. This work is published under https://www.jpatholtm.org/articles/archive.php (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2021 The Korean Society of Pathologists/The Korean Society for Cytopathology 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4369-22ab409c4cb13c08c13da42115f1d5d2a17d4713aa7e401e1778f9d20dac14d3</citedby><cites>FETCH-LOGICAL-c4369-22ab409c4cb13c08c13da42115f1d5d2a17d4713aa7e401e1778f9d20dac14d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2504869268/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2504869268?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,74998</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33260285$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002694503$$DAccess content in National Research Foundation of Korea (NRF)$$Hfree_for_read</backlink></links><search><creatorcontrib>Yoo, Youngeun</creatorcontrib><creatorcontrib>Lee, Junghye</creatorcontrib><creatorcontrib>Park, Heae Surng</creatorcontrib><creatorcontrib>Cho, Min-Sun</creatorcontrib><creatorcontrib>Sung, Sun Hee</creatorcontrib><creatorcontrib>Park, Sanghui</creatorcontrib><creatorcontrib>Choi, Euno</creatorcontrib><title>Histologically confirmed distant metastatic urothelial carcinoma from the urinary bladder: a retrospective review of one institution's 20-year experience</title><title>Journal of pathology and translational medicine</title><addtitle>J Pathol Transl Med</addtitle><description>Urothelial carcinoma (UC) accounts for roughly 90% of bladder cancer, and has a high propensity for diverse differentiation. Recently, certain histologic variants of UC have been recognized to be associated with unfavorable clinical outcomes. Several UC studies have also suggested that tumor budding is a poor prognostic marker. Distant metastasis of UC after radical cystectomy is not uncommon. However, these metastatic lesions are not routinely confirmed with histology.
We investigated the histopathologic features of 13 cases of UC with biopsy-proven distant metastases, with a special emphasis on histologic variants and tumor budding.
Lymph nodes (6/13, 46%) were the most common metastatic sites, followed by the lung (4/13, 31%), liver (4/13, 31%), and the adrenal gland (2/13, 15%). The histologic variants including squamous (n=1), micropapillary (n=4), and plasmacytoid (n=1) variants in five cases of UC. Most histologic variants (4/5, 80%) of primary UCs appeared in the metastatic lesions. In contrast, high-grade tumor budding was detected in six cases (46%), including one case of non-muscle invasive UC. Our study demonstrates that histologic variants are not uncommonly detected in distant metastatic UCs. Most histologic variants seen in primary UCs persist in the distant metastatic lesions. In addition, high-grade tumor budding, which occurs frequently in primary tumors, may contribute to the development of distant metastasis.
Therefore, assessing the presence or absence of histologic variants and tumor budding in UCs of the urinary bladder, even in non-muscle invasive UCs, may be useful to predict distant metastasis.</description><subject>Adrenal glands</subject><subject>Biopsy</subject><subject>Bladder cancer</subject><subject>bladder neoplasms</subject><subject>Clinical outcomes</subject><subject>distant metastasis</subject><subject>histologic variant</subject><subject>Liver</subject><subject>Lymphatic system</subject><subject>Metastasis</subject><subject>Original</subject><subject>Patients</subject><subject>tumor budding</subject><subject>Tumors</subject><subject>urothelial carcinoma</subject><subject>병리학</subject><issn>2383-7837</issn><issn>2383-7845</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNpdUk1vEzEQXSEQrUrP3JAlDsAhqb92veaAVFVAI1VCQrlbE3s2dbprB68TyE_h3-IkJaKcZvzm-Wk-XlW9ZnQqmeBXq3UeppxyOi0I08-qcy5aMVGtrJ-fcqHOqstxXFFKmaxFI_XL6kwI3lDe1ufV71s_5tjHpbfQ9ztiY-h8GtARVwoQMhkwQ8myt2STYr7H3kNPLCTrQxyAdCkOpMCl6gOkHVn04BymjwRIwpziuEab_RbLa-vxJ4kdiQGJD2P2eZN9DO9Gwulkh5AI_lpj8hgsvqpedNCPePkYL6r5l8_zm9vJ3bevs5vru4mVotETzmEhqbbSLpiwtLVMOJCcsbpjrnYcmHJSMQGgUFKGTKm2045TB5ZJJy6qD0fZkDrzYL2J4A9xGc1DMtff5zOjVSMY44U7O3JdhJVZJz-UeQ8fDkBMSwOpLKpHI2qu285aCq6RjjlQStY1cxSpFp2qi9ano9Z6syjrthhygv6J6NNK8Pelp61RulU1Z0Xg_aNAij82OGYz-NFi30PAuBkNl03DNVdaF-rb_6iruEmhbNXwmsq20bxpC-vqyLLlZmPC7tQMo2ZvOLM3nNkbbo-wve6bf2c48f_aS_wBToPUmw</recordid><startdate>202103</startdate><enddate>202103</enddate><creator>Yoo, Youngeun</creator><creator>Lee, Junghye</creator><creator>Park, Heae Surng</creator><creator>Cho, Min-Sun</creator><creator>Sung, Sun Hee</creator><creator>Park, Sanghui</creator><creator>Choi, Euno</creator><general>Korean Society of Pathologists, Korean Society for Cytopathology</general><general>The Korean Society of Pathologists and the Korean Society for Cytopathology</general><general>Korean Society of Pathologists & the Korean Society for Cytopathology</general><general>대한병리학회</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7XB</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BVBZV</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><scope>ACYCR</scope></search><sort><creationdate>202103</creationdate><title>Histologically confirmed distant metastatic urothelial carcinoma from the urinary bladder: a retrospective review of one institution's 20-year experience</title><author>Yoo, Youngeun ; Lee, Junghye ; Park, Heae Surng ; Cho, Min-Sun ; Sung, Sun Hee ; Park, Sanghui ; Choi, Euno</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4369-22ab409c4cb13c08c13da42115f1d5d2a17d4713aa7e401e1778f9d20dac14d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Adrenal glands</topic><topic>Biopsy</topic><topic>Bladder cancer</topic><topic>bladder neoplasms</topic><topic>Clinical outcomes</topic><topic>distant metastasis</topic><topic>histologic variant</topic><topic>Liver</topic><topic>Lymphatic system</topic><topic>Metastasis</topic><topic>Original</topic><topic>Patients</topic><topic>tumor budding</topic><topic>Tumors</topic><topic>urothelial carcinoma</topic><topic>병리학</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yoo, Youngeun</creatorcontrib><creatorcontrib>Lee, Junghye</creatorcontrib><creatorcontrib>Park, Heae Surng</creatorcontrib><creatorcontrib>Cho, Min-Sun</creatorcontrib><creatorcontrib>Sung, Sun Hee</creatorcontrib><creatorcontrib>Park, Sanghui</creatorcontrib><creatorcontrib>Choi, Euno</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest East & South Asia Database</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Research Library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><collection>Korean Citation Index (Open Access)</collection><jtitle>Journal of pathology and translational medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yoo, Youngeun</au><au>Lee, Junghye</au><au>Park, Heae Surng</au><au>Cho, Min-Sun</au><au>Sung, Sun Hee</au><au>Park, Sanghui</au><au>Choi, Euno</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Histologically confirmed distant metastatic urothelial carcinoma from the urinary bladder: a retrospective review of one institution's 20-year experience</atitle><jtitle>Journal of pathology and translational medicine</jtitle><addtitle>J Pathol Transl Med</addtitle><date>2021-03</date><risdate>2021</risdate><volume>55</volume><issue>2</issue><spage>94</spage><epage>101</epage><pages>94-101</pages><issn>2383-7837</issn><eissn>2383-7845</eissn><abstract>Urothelial carcinoma (UC) accounts for roughly 90% of bladder cancer, and has a high propensity for diverse differentiation. Recently, certain histologic variants of UC have been recognized to be associated with unfavorable clinical outcomes. Several UC studies have also suggested that tumor budding is a poor prognostic marker. Distant metastasis of UC after radical cystectomy is not uncommon. However, these metastatic lesions are not routinely confirmed with histology.
We investigated the histopathologic features of 13 cases of UC with biopsy-proven distant metastases, with a special emphasis on histologic variants and tumor budding.
Lymph nodes (6/13, 46%) were the most common metastatic sites, followed by the lung (4/13, 31%), liver (4/13, 31%), and the adrenal gland (2/13, 15%). The histologic variants including squamous (n=1), micropapillary (n=4), and plasmacytoid (n=1) variants in five cases of UC. Most histologic variants (4/5, 80%) of primary UCs appeared in the metastatic lesions. In contrast, high-grade tumor budding was detected in six cases (46%), including one case of non-muscle invasive UC. Our study demonstrates that histologic variants are not uncommonly detected in distant metastatic UCs. Most histologic variants seen in primary UCs persist in the distant metastatic lesions. In addition, high-grade tumor budding, which occurs frequently in primary tumors, may contribute to the development of distant metastasis.
Therefore, assessing the presence or absence of histologic variants and tumor budding in UCs of the urinary bladder, even in non-muscle invasive UCs, may be useful to predict distant metastasis.</abstract><cop>Korea (South)</cop><pub>Korean Society of Pathologists, Korean Society for Cytopathology</pub><pmid>33260285</pmid><doi>10.4132/jptm.2020.10.19</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2383-7837 |
ispartof | Journal of Pathology and Translational Medicine, 2021, 55(2), , pp.94-101 |
issn | 2383-7837 2383-7845 |
language | eng |
recordid | cdi_nrf_kci_oai_kci_go_kr_ARTI_9763112 |
source | Publicly Available Content Database; PubMed Central |
subjects | Adrenal glands Biopsy Bladder cancer bladder neoplasms Clinical outcomes distant metastasis histologic variant Liver Lymphatic system Metastasis Original Patients tumor budding Tumors urothelial carcinoma 병리학 |
title | Histologically confirmed distant metastatic urothelial carcinoma from the urinary bladder: a retrospective review of one institution's 20-year experience |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T17%3A03%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_nrf_k&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Histologically%20confirmed%20distant%20metastatic%20urothelial%20carcinoma%20from%20the%20urinary%20bladder:%20a%20retrospective%20review%20of%20one%20institution's%2020-year%20experience&rft.jtitle=Journal%20of%20pathology%20and%20translational%20medicine&rft.au=Yoo,%20Youngeun&rft.date=2021-03&rft.volume=55&rft.issue=2&rft.spage=94&rft.epage=101&rft.pages=94-101&rft.issn=2383-7837&rft.eissn=2383-7845&rft_id=info:doi/10.4132/jptm.2020.10.19&rft_dat=%3Cproquest_nrf_k%3E2504869268%3C/proquest_nrf_k%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4369-22ab409c4cb13c08c13da42115f1d5d2a17d4713aa7e401e1778f9d20dac14d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2504869268&rft_id=info:pmid/33260285&rfr_iscdi=true |